Cite
Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma
MLA
Li-Yu Lee, et al. “Whole-Exome Sequencing Identifies Biosignatures That Predict Adverse Survival Outcomes in Surgically Treated Patients with Oral Cavity Squamous Cell Carcinoma.” Oral Oncology, vol. 122, Nov. 2021, p. 105547. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a8d49ce89796eb59b20074a4b6a528af&authtype=sso&custid=ns315887.
APA
Li-Yu Lee, Tzu-Chen Yen, Chien-Yu Lin, Shu-Hang Ng, Chun-Ta Liao, Jason Chia-Hsun Hsieh, Lan-Yan Yang, Hung-Ming Wang, & Wen-Lang Fan. (2021). Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma. Oral Oncology, 122, 105547.
Chicago
Li-Yu Lee, Tzu-Chen Yen, Chien-Yu Lin, Shu-Hang Ng, Chun-Ta Liao, Jason Chia-Hsun Hsieh, Lan-Yan Yang, Hung-Ming Wang, and Wen-Lang Fan. 2021. “Whole-Exome Sequencing Identifies Biosignatures That Predict Adverse Survival Outcomes in Surgically Treated Patients with Oral Cavity Squamous Cell Carcinoma.” Oral Oncology 122 (November): 105547. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a8d49ce89796eb59b20074a4b6a528af&authtype=sso&custid=ns315887.